50th Anniversary of the First Surgeon General's Report on Smoking and Health
On January 17, 2014, 50 years after the first Surgeon General's report on smoking and health, the Surgeon General will release The Health Consequences of Smoking-50 Years of Progress (1) . The report will be released at a White House press conference at 9:30 a.m. Eastern on January 17, with a live webcast available at http://whitehouse.gov/live.
The report will provide a retrospective of the past 50 years of tobacco use prevention and control efforts and discuss the current status of the tobacco use epidemic, including newly documented health consequences of smoking and exposure to secondhand smoke. It will also include a discussion of potential "endgame" strategies to eliminate the health and economic burden of tobacco use in the United States.
Evidence-based tobacco control efforts have averted nearly 8 million deaths since 1964 but remain underutilized (2) . High-impact media campaigns, excise taxes, access to cessation medication and counseling, smoke-free laws, comprehensive tobacco control programs, and product regulation are critical to ending the tobacco use epidemic.
Current Cigarette Smoking Among Adults -United States, 2005-2012
Israel T. Agaku, DMD 1,2 , Brian A. King, PhD 2 , Shanta R. Dube, PhD 2 (Author affiliations at end of text) Despite significant declines during the past 30 years, cigarette smoking among adults in the United States remains widespread, and year-to-year decreases in prevalence have been observed only intermittently in recent years (1, 2) . To assess progress made toward the Healthy People 2020 objective of reducing the proportion of U.S. adults who smoke cigarettes to ≤12% (objective TU-1.1),* this report provides the most recent national estimates of smoking prevalence among adults aged ≥18 years, based on data from the 2012 National Health Interview Survey (NHIS). The findings indicate that the proportion of U.S. adults who smoke cigarettes fell to 18.1% in 2012. Moreover, during 2005-2012, the percentage of ever smokers who quit increased significantly, from 50.7% to 55.0%, and the proportion of daily smokers who smoked ≥30 cigarettes per day (CPD) declined significantly, from 12.6% to 7.0%. Proven population-level interventions, including tobacco price increases, high-impact antitobacco mass media campaigns, comprehensive smoke-free laws, and barrier-free access to help quitting, are critical to decreasing cigarette smoking and reducing the health and economic burden of tobacco-related diseases in the United States (3).
NHIS is an annual, nationally representative, in-person survey of the noninstitutionalized U.S. civilian population. Questions about cigarette smoking are directed to one randomly selected adult from each surveyed family. In 2012, a total of 34,525 adults aged ≥18 years were selected and participated, yielding a 61.2% response rate. Current smokers were respondents who reported smoking ≥100 cigarettes during their lifetime and, at the time of interview, reported smoking every day or some days. Former smokers were respondents who reported smoking ≥100 cigarettes during their lifetime but currently did not smoke. The mean number of CPD was calculated among daily current smokers. A quit attempt was defined as a report by a current smoker that they stopped smoking for >1 day during the preceding year because they were trying to quit smoking, or a report by a former smoker that they quit smoking during the preceding year. † Quit ratios were defined as the ratio of former smokers to ever smokers.
Data were adjusted for nonresponse and weighted to provide nationally representative estimates. Current smoking was assessed overall and by sex, age, race/ethnicity, education, poverty status, § U.S. Census region, ¶ and disability/limitation status.** Differences between groups were assessed using the chi-squared statistic and 95% confidence intervals. Quit ratios were calculated overall and by age group. (Figure 1 ) (p<0.05 for trend).
Among current smokers and former smokers who quit during the preceding year, 52.9% had made a quit attempt for >1 day. The overall quit ratio (i.e., the ratio of former to ever smokers) increased from 50.7% in 2005 to 55.0% in 2012 (Figure 2) 
Editorial Note
During 2005-2012, cigarette smoking prevalence declined among U.S. adults, and the quit ratio (i.e., the percentage of ever smokers who had quit) increased. During the same period, the proportion of daily smokers who smoked ≥30 CPD also declined. Adults aged 18-24 years had the greatest decrease in cigarette smoking prevalence; however, this decline might be attributable, in part, to the use of other tobacco products, such as flavored little cigars, which are especially popular with this age group (4).
The decline in overall smoking prevalence from 20.9% in 2005 to 18.1% in 2012 is encouraging and likely reflects the success of tobacco control efforts across the country. However, given the slowing decline in adult smoking in recent years, continued implementation of evidence-based interventions outlined in the World Health Organization MPOWER , and the number of unique visitors to a smoking cessation website (http://www. smokefree.gov) increased 428% (5) . Additionally, an estimated 1.6 million quit attempts were attributable to the campaign (6) . Disparities in smoking prevalence described in this report are consistent with previous studies (2) . Variations across racial/ ethnic groups might be attributable, in part, to targeted tobacco product marketing or differences in the social acceptability of smoking, whereas disparities by education might be related to differences in understanding of the health hazards of smoking and increased vulnerability to tobacco marketing. Differences by disability/limitation status might be attributable, in part, to smoking-attributable disability in smokers and increased stress associated with disabilities (7). The high smoking prevalence observed among some population groups underscores the need for enhanced implementation and reach of proven strategies to prevent and reduce tobacco use among these groups.
The findings in this report are subject to at least six limitations. First, smoking status was self-reported and not validated by biochemical testing. However, self-reported smoking status correlates highly with serum cotinine levels (8) . Second, small sample sizes for certain population groups resulted in less precise estimates. Third, data could not be disaggregated for specific racial/ethnic subgroups; although smoking prevalence was lowest among Hispanics and non-Hispanic Asians, variability in smoking prevalence exists among Hispanic and Asian subpopulations (9) . Fourth, because NHIS does not include institutionalized populations and persons in the military, results might not be generalizable to these groups. Fifth, the NHIS response rate of 61.2% might have resulted in nonresponse bias, even after adjustment for nonresponse. Finally, these estimates might differ from those derived from other surveillance systems. For example, the National Survey on Drug Use and Health consistently yields higher current smoking estimates than NHIS (10). These differences can be explained, in part, by the varying survey methodologies, the types of surveys administered, and the definitions of current smoking that are used. However, trends in prevalence are comparable across surveys.
Sustained, comprehensive state tobacco control programs funded at CDC-recommended levels accelerate progress toward reducing the health burden and economic impact of tobacco-related diseases in the United States (3 What are the implications for public health practice?
Effective public health interventions that can continue progress toward meeting the Healthy People 2020 target to reduce U.S. adult cigarette smoking to ≤12% include a combination of tobacco price increases, high-impact antitobacco mass media campaigns, comprehensive smoke-free laws, and barrier-free access to help quitting.
moreover, only two states (Alaska and North Dakota) currently fund tobacco control programs at CDC-recommended levels. § § § Implementation of comprehensive tobacco control policies and programs can result in a substantial reduction in tobacco-related morbidity and mortality and billions of dollars in savings from averted medical costs (3).
